FDA staffing shortage hampers hiring, raising oversight concerns

The FDA lacks sufficient staff to process new hires, creating a bottleneck that could delay regulatory reviews and oversight. This is an administrative constraint with potential downstream effects on drug approvals and public health readiness. The situation is reported by STAT, with no independent confirmation of the exact staffing shortfall.